1 | H-116PI-DE.pdf | - | - | - | - | 1件: 18 18 |
2 | H-ATG (ATGAM ) | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
3 | H.P. Acthar Gel | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 46 46, 49, 50, 84, 222 |
4 | H.P. Acthar Gel (repository corticotropin injection) | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 |
5 | H.P. Acthar® Gel | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 14 14 |
6 | H01AC01 | - | - | - | - | 1件: 78 78 |
7 | H01BB02 | - | - | - | - | 1件: 193 193 |
8 | H02 - Corticosteroidi Sistemici | - | - | - | - | 1件: 299 299 |
9 | H02AB | - | - | - | - | 1件: 97 97 |
10 | H02AB02 | - | - | - | - | 1件: 28 28 |
11 | H02AB02 Desametasone | - | - | - | - | 1件: 28 28 |
12 | H02AB04 | - | - | - | - | 1件: 46 46 |
13 | H02AB07 | - | - | - | - | 1件: 46 46 |
14 | H02AB09 | - | - | - | - | 1件: 41 41 |
15 | H05AA02 | - | - | - | - | 1件: 274 274 |
16 | H1 Blocker | - | - | - | - | 1件: 257 257 |
17 | H2 Blocker | - | - | - | - | 1件: 257 257 |
18 | H44AON188 | - | - | - | - | 1件: 113 113 |
19 | H51AON23 | - | - | - | - | 1件: 113 113 |
20 | H5G1.1-mAb | - | - | - | - | 3件: 13 13, 50, 62 |
21 | HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM | - | - | - | - | 2件: 6 6, 49 |
22 | HA20 (IMMU-106) | - | - | - | - | 1件: 46 46 |
23 | Habitrol | - | - | - | - | 1件: 84 84 |
24 | Haemate P | - | - | - | - | 1件: 288 288 |
25 | Haemate P® (Human Coagulation Factor VIII) | 1件: Antihemophilic factor human Antihemophilic factor human | - | - | - | 1件: 288 288 |
26 | Haemate-P, Wilate | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
27 | Haemate® P 250 | - | - | - | - | 1件: 288 288 |
28 | Haemoblock | - | - | - | - | 2件: 157 157, 280 |
29 | Haemocomplettan P | - | - | - | - | 1件: 65 65 |
30 | Haemocomplettan(R) P | - | - | - | - | 1件: 65 65 |
31 | Haemocomplettan(R) P 1g/2g | - | - | - | - | 1件: 65 65 |
32 | HAEMOPHILUS INFLUENZAE | - | - | - | - | 3件: 61 61, 62, 66 |
33 | HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | - | - | - | 2件: 13 13, 14 |
34 | Haemophilus type b vaccine (conjugated) | - | - | - | - | 1件: 14 14 |
35 | Haemostasis tests | - | - | - | - | 1件: 113 113 |
36 | Halometasone | 1件: Halometasone Halometasone | 1件: D07202
D07202
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 |
37 | Haloperidol | 1件: Haloperidol Haloperidol | 2件: D00136
D00136
,
D01898
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 8 8 |
38 | Haloperidol 2Mg Tab | 1件: Haloperidol Haloperidol | 2件: D00136
D00136
,
D01898
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 8 8 |
39 | Haplo BM with T cell depletion | - | - | - | - | 1件: 65 65 |
40 | Haplo HSCT | - | - | - | - | 1件: 60 60 |
41 | Haplo/cord transplant | - | - | - | - | 1件: 60 60 |
42 | Haploidentical Hematopoietic Cell Transplantation | - | - | - | - | 2件: 60 60, 65 |
43 | Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide'' | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
,
D07760
| - | - | 1件: 60 60 |
44 | Harmonized supportive care | - | - | - | - | 2件: 38 38, 39 |
45 | Harvoni | 1件: Sofosbuvir Sofosbuvir | 1件: D10366
D10366
| - | - | 1件: 254 254 |
46 | HATG | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
47 | Havrix | - | - | - | - | 1件: 46 46 |
48 | HB-adMSCs | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 7件: 2 2, 4, 6, 13, 46, 49, 113 |
49 | HBM9161 Dose A | - | - | - | - | 1件: 63 63 |
50 | HBM9161 Dose B | - | - | - | - | 1件: 63 63 |
51 | HBM9161 Injection | - | - | - | - | 1件: 13 13 |
52 | HBM9161 Injection (340 mg) | - | - | - | - | 1件: 11 11 |
53 | HBM9161 Injection (680mg and 340 mg) | - | - | - | - | 1件: 11 11 |
54 | HBM9161 Injection (680mg) | - | - | - | - | 1件: 11 11 |
55 | HBVAXPRO | - | - | - | - | 2件: 46 46, 50 |
56 | HBVAXPRO 5 micrograms/0.5 ml | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
57 | HBVAXPRO 5 micrograms/0.5 ml Suspension for injection Hepatitis B vaccine (rDNA) | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
58 | HBVAXPRO® 40 micrograms | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
59 | HC-58 | - | - | - | - | 1件: 149 149 |
60 | HCQ | - | - | - | - | 2件: 46 46, 49 |
61 | HCQ/CQ and CAB combined treatment | - | - | - | - | 1件: 74 74 |
62 | HCT | - | - | - | - | 1件: 67 67 |
63 | HD-TIV | - | - | - | - | 1件: 46 46 |
64 | HE3286 | 1件: HE3286 HE3286 | - | - | - | 2件: 46 46, 97 |
65 | HEC 68498 | - | - | - | - | 1件: 85 85 |
66 | HEC122505MsOH | - | - | - | - | 1件: 6 6 |
67 | HEC585 | - | - | - | - | 1件: 85 85 |
68 | Helicobacter pylori eradication therapy | - | - | - | - | 1件: 6 6 |
69 | Helium | 1件: Helium Helium | 1件: D04420
D04420
| - | - | 3件: 228 228, 299, 330 |
70 | Helium / oxygen mixed gas inhalation therapy | 2件: Helium Helium, Oxygen | 2件: D00003
D00003
,
D04420
| - | - | 1件: 330 330 |
71 | Helium-3 | 2件: Helium Helium, Helium He-3 | 1件: D04420
D04420
| - | - | 2件: 228 228, 299 |
72 | Helminth ova | - | - | - | - | 1件: 13 13 |
73 | Helopanflat Mono® | - | - | - | - | 1件: 298 298 |
74 | Hematide | 1件: Peginesatide Peginesatide | 1件: D09946
D09946
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 283 283 |
75 | Hematide, peginesatide | 1件: Peginesatide Peginesatide | 1件: D09946
D09946
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 283 283 |
76 | Hematopoetic stem cell infusion | - | - | - | - | 1件: 13 13 |
77 | Hematopoetic Stem Cell Transplantation | - | - | - | - | 5件: 19 19, 65, 120, 160, 326 |
78 | Hematopoietic bone marrow transplantation | - | - | - | - | 1件: 36 36 |
79 | Hematopoietic Cell Transplantation | - | - | - | - | 1件: 60 60 |
80 | Hematopoietic stem cell infusion | - | - | - | - | 2件: 19 19, 20 |
81 | Hematopoietic Stem Cell Therapy | - | - | - | - | 1件: 13 13 |
82 | Hematopoietic Stem Cell Transplant | - | - | - | - | 2件: 65 65, 285 |
83 | Hematopoietic Stem Cell Transplantation | - | - | - | - | 13件: 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 |
84 | Hematopoietic stem cell transplantation (HSCT) | - | - | - | - | 2件: 13 13, 60 |
85 | Hemay005 | - | - | - | - | 1件: 56 56 |
86 | Hemay007 | - | - | - | - | 1件: 97 97 |
87 | Hemay007 1200 mg QD group | - | - | - | - | 1件: 46 46 |
88 | Hemay007 600 mg QD group | - | - | - | - | 1件: 46 46 |
89 | Hemay007 800 mg QD group | - | - | - | - | 1件: 46 46 |
90 | Heme arginate | - | - | - | - | 1件: 254 254 |
91 | Hemin | 1件: Hemin Hemin | 1件: D10003
D10003
| 2件: ALAS1 ALAS1, ALAS2 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬 | 1件: 254 254 |
92 | Hemin for injection | 1件: Hemin Hemin | 1件: D10003
D10003
| 2件: ALAS1 ALAS1, ALAS2 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬 | 1件: 254 254 |
93 | Hemlibra | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
94 | Hemlibra® | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
95 | HEMOFIX | - | - | - | - | 1件: 288 288 |
96 | Hemoglobin | 1件: Hemoglobin Hemoglobin | - | - | - | 1件: 298 298 |
97 | Heparesc | - | - | - | - | 1件: 251 251 |
98 | Heparin | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 12件: 47 47, 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317 |
99 | Heparin & Alkalinized Lidocaine Bladder Instillation | 2件: Heparin Heparin, Lidocaine | 4件: D00358
D00358
,
D02086
,
D07510
,
D08127
| 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 | 4件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬 | 1件: 226 226 |
100 | Heparin 25mg inhalation powder, hard capsule | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 299 299 |
101 | Heparin Sodium | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 280 280, 299 |
102 | Heparin-induced extracorporeal LDL precipitation | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 79 79 |
103 | Heparán N sulfatasa humana recombinante | - | - | - | - | 1件: 19 19 |
104 | Heparán N sulfatasa humana recombinante (rhHNS) | - | - | - | - | 1件: 19 19 |
105 | HepaStem | - | - | - | - | 1件: 251 251 |
106 | HepaStem Infusion | - | - | - | - | 1件: 251 251 |
107 | Hepatitis A Vaccine | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 3件: 46 46, 96, 97 |
108 | Hepatitis A vaccine ( HAVRIX or EPAXAL) | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 1件: 46 46 |
109 | Hepatitis A vaccine and tetanus vaccine | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 1件: 46 46 |
110 | Hepatitis B Vaccine | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
111 | HEPATITIS B VACCINE (RDNA) | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
112 | HEPATITIS B VIRUS SURFACE ANTIGEN RECOMBINANT (S PROTEIN) | - | - | - | - | 1件: 46 46 |
113 | Hepatocyte Transplant | - | - | - | - | 1件: 240 240 |
114 | Heptaminol | 1件: Heptaminol Heptaminol | 1件: D07158
D07158
| - | - | 1件: 6 6 |
115 | Heptaminol hydrochloride | 1件: Heptaminol Heptaminol | 1件: D07158
D07158
| - | - | 1件: 6 6 |
116 | Heracillin | - | - | - | - | 1件: 299 299 |
117 | Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.) | 1件: Reynoutria multiflora root Reynoutria multiflora root | - | - | - | 1件: 6 6 |
118 | Herbal medicine | - | - | - | - | 1件: 70 70 |
119 | Herbal treatment (SA100) | - | - | - | - | 1件: 97 97 |
120 | Hericium erinaceus mycelium | - | - | - | - | 1件: 6 6 |
121 | Herpes Zoster Vaccine | - | - | - | - | 3件: 46 46, 96, 271 |
122 | HESC-RPE | - | - | - | - | 1件: 301 301 |
123 | Heshouwu | 1件: Reynoutria multiflora root Reynoutria multiflora root | - | - | - | 1件: 6 6 |
124 | Heterologous booster | - | - | - | - | 1件: 13 13 |
125 | Heterologous Human Adult Liver-derived Progenitor Cells | - | - | - | - | 1件: 251 251 |
126 | Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC) | - | - | - | - | 1件: 251 251 |
127 | Hetrombopag | 1件: Hetrombopag Hetrombopag | - | - | - | 2件: 60 60, 63 |
128 | Hetrombopag Olamine | 1件: Hetrombopag Hetrombopag | - | - | - | 2件: 60 60, 63 |
129 | Hetrombopag Olamine Tablet | 1件: Hetrombopag Hetrombopag | - | - | - | 1件: 60 60 |
130 | Hetrombopag Olamine+Standard Therapy | 1件: Hetrombopag Hetrombopag | - | - | - | 1件: 60 60 |
131 | Hextend | 1件: Hydroxyethyl Starch Hydroxyethyl Starch | 1件: D03335
D03335
| - | - | 2件: 96 96, 97 |
132 | HF0220 | - | - | - | - | 1件: 6 6 |
133 | HF2 | - | - | - | - | 1件: 97 97 |
134 | HFNT during exercise | - | - | - | - | 1件: 299 299 |
135 | Hgd40 | - | - | - | - | 1件: 97 97 |
136 | HGH | - | - | - | - | 1件: 78 78 |
137 | HGH-hyFc, recombinant human growth hormone | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 78 78 |
138 | HGH-ViaDerm™ System | - | - | - | - | 1件: 78 78 |
139 | HGH-ViaDerm™ System (hGH or somatropin) | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 78 78 |
140 | HGP1206 | - | - | - | - | 1件: 86 86 |
141 | HGPIV diagnosis test | - | - | - | - | 1件: 299 299 |
142 | HGS1006 | - | - | - | - | 1件: 49 49 |
143 | HGS1006, LymphoStat-B | - | - | - | - | 1件: 53 53 |
144 | HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA | 1件: Belimumab Belimumab | 1件: D03068
D03068
| 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 49 49, 53 |
145 | HGS1025 | - | - | - | - | 1件: 97 97 |
146 | HGT-1110 | - | - | - | - | 1件: 19 19 |
147 | HGT-1111 | - | - | - | - | 1件: 19 19 |
148 | HGT-1410 | - | - | - | - | 1件: 19 19 |
149 | HGT-2310 | - | - | - | - | 1件: 19 19 |
150 | HHALPC | - | - | - | - | 1件: 251 251 |
151 | HHLivC | - | - | - | - | 1件: 251 251 |
152 | Hiberix | 1件: Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 4件: 13 13, 61, 62, 66 |
153 | HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML | 1件: Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 3件: 61 61, 62, 66 |
154 | HIDONAC*EV 1FL 5G 25ML | - | - | - | - | 1件: 51 51 |
155 | Hidrocloruro de efedrina | 1件: Ephedrine Ephedrine | 1件: D00124
D00124
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 11 11 |
156 | Hidrocloruro de fingolimod | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 14 |
157 | HIDROFEROL | - | - | - | - | 1件: 113 113 |
158 | Hidroferol® | - | - | - | - | 1件: 113 113 |
159 | HIDS DONOR | - | - | - | - | 1件: 19 19 |
160 | High cheese intake. | - | - | - | - | 1件: 238 238 |
161 | High Cut-off Hemodialysis | - | - | - | - | 1件: 28 28 |
162 | High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device | - | - | - | - | 1件: 226 226 |
163 | High Dietary Sodium | - | - | - | - | 1件: 49 49 |
164 | High dose | - | - | - | - | 1件: 97 97 |
165 | High dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | 1件: 6 6 |
166 | High dose ANAVEX2-73 | - | - | - | - | 1件: 6 6 |
167 | High Dose Aspirin (1300 mg/day) | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
168 | High dose BIBF 1120 twice daily | - | - | - | - | 1件: 85 85 |
169 | High Dose Budesonide | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
170 | High dose budesonide suspension | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
171 | High dose budesonide tablet | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
172 | High dose Dexamethasone pulses | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
173 | High dose lactulose | 1件: Lactulose Lactulose | 1件: D00352
D00352
| - | - | 1件: 291 291 |
174 | High dose levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
175 | High Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | 1件: 49 49 |
176 | High Dose MT-1303 | - | - | - | - | 1件: 97 97 |
177 | High dose of BIIL 284 BS tablets | - | - | - | - | 1件: 46 46 |
178 | High dose of budesonide | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 |
179 | High dose ORTD-1 | - | - | - | - | 1件: 46 46 |
180 | High dose TSO | - | - | - | - | 1件: 96 96 |
181 | High dose vehicle control | - | - | - | - | 1件: 46 46 |
182 | High Dose-VIS649 | - | - | - | - | 1件: 66 66 |
183 | High doses of Thiamine y Biotin | 2件: Biotin Biotin, Thiamine | 2件: D00029
D00029
,
D08580
| - | - | 1件: 8 8 |
184 | High flow nasal oxygen cannula | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 299 299 |
185 | High frequency ultrasonography | - | - | - | - | 1件: 46 46 |
186 | High milk intake. | - | - | - | - | 1件: 238 238 |
187 | High oleic sunflower oil | 1件: Sunflower oil Sunflower oil | 1件: D09006
D09006
| - | - | 1件: 240 240 |
188 | High Oligosaccharide Group | - | - | - | - | 1件: 96 96 |
189 | High Phenolic Extra Virgin Olive Oil | 2件: Olea europaea leaf Olea europaea leaf, Olive oil | 1件: D03311
D03311
| - | - | 1件: 13 13 |
190 | High Protein and Low Fiber Diet | - | - | - | - | 1件: 97 97 |
191 | High protein high fiber diet | - | - | - | - | 2件: 93 93, 95 |
192 | High Protein. T-Diet plus Range | - | - | - | - | 1件: 6 6 |
193 | High serine diet | 1件: Serine Serine | 1件: D00016
D00016
| - | - | 1件: 96 96 |
194 | High water intake | 1件: Water Water | 1件: D00001
D00001
| - | - | 1件: 67 67 |
195 | High-caloric fatty diet | - | - | - | - | 1件: 2 2 |
196 | High-carbohdyrate breakfast | - | - | - | - | 1件: 265 265 |
197 | High-dose Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
,
D07760
| - | - | 1件: 96 96 |
198 | High-dose intravenous immunoglobulin (IVIG) | - | - | - | - | 1件: 18 18 |
199 | High-dose intravenous immunoglobulin (Venoglobulin-IH) | - | - | - | - | 1件: 51 51 |
200 | High-dose REGN4461 | - | - | - | - | 1件: 265 265 |
201 | High-dose vitamin D (2000 IU per day) | 1件: Vitamin D Vitamin D | - | - | - | 1件: 274 274 |
202 | High-Dose Vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
203 | High-Frequency-Only Stimulation | - | - | - | - | 1件: 6 6 |
204 | High-resolution peripheral quantitative computed tomography (HR-pQCT) | - | - | - | - | 1件: 46 46 |
205 | High/Low Sodium Diet | - | - | - | - | 1件: 13 13 |
206 | Hiomega-3 supplement of Naturalis® company - | - | - | - | - | 1件: 49 49 |
207 | Histamine | 1件: Histamine Histamine | 1件: D08040
D08040
| 4件: HRH1 HRH1, HRH2, HRH3, HRH4 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
208 | Histidine | 1件: Histidine Histidine | 1件: D00032
D00032
| - | - | 3件: 13 13, 169, 170 |
209 | Histone Deacetylase Inhibitor | - | - | - | - | 1件: 127 127 |
210 | History and physical | - | - | - | - | 1件: 231 231 |
211 | History and physical exam. | - | - | - | - | 2件: 231 231, 299 |
212 | Histrelin | 1件: Histrelin Histrelin | 1件: D02369
D02369
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
213 | Histrelin Subcutaneous Implant | 1件: Histrelin Histrelin | 1件: D02369
D02369
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
214 | Hizentra | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 4件: 14 14, 50, 51, 65 |
215 | HIZENTRA ® | - | - | - | - | 1件: 11 11 |
216 | Hizentra® | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 2件: 14 14, 65 |
217 | HK-001 | - | - | - | - | 1件: 2 2 |
218 | HL237 | - | - | - | - | 1件: 46 46 |
219 | HL237 tablet | - | - | - | - | 1件: 46 46 |
220 | HLA-identical allogeneic mesoangioblasts | - | - | - | - | 1件: 113 113 |
221 | HLB-001 | - | - | - | - | 1件: 246 246 |
222 | HLL2 | - | - | - | - | 1件: 49 49 |
223 | HLL2 (Epratuzumab) | 1件: Epratuzumab Epratuzumab | 1件: D04036
D04036
| 1件: CD22 CD22 💬 | 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 |
224 | HLL2 (trivial name or chemical description) | - | - | - | - | 1件: 49 49 |
225 | HLL2,IMMU-103 | - | - | - | - | 1件: 49 49 |
226 | HLX01 | - | - | - | - | 1件: 46 46 |
227 | HM10560A | - | - | - | - | 1件: 78 78 |
228 | HM201 | - | - | - | - | 2件: 96 96, 97 |
229 | HM71224 food effect | - | - | - | - | 1件: 46 46 |
230 | HM71224 Multiple ascending dose | - | - | - | - | 1件: 46 46 |
231 | HM71224 single ascending dose | - | - | - | - | 1件: 46 46 |
232 | HMABs | - | - | - | - | 1件: 113 113 |
233 | HMED-IdeS | 1件: Imlifidase Imlifidase | 1件: D11470
D11470
| - | - | 2件: 64 64, 221 |
234 | HMG-Coenzyme inhibitor (statin) | - | - | - | - | 1件: 218 218 |
235 | HMI-103 | - | - | - | - | 1件: 240 240 |
236 | HMPL-004 | - | - | - | - | 2件: 96 96, 97 |
237 | HMPL-004 1800 mg/day | - | - | - | - | 1件: 97 97 |
238 | HMPL-004 2400 mg/day | - | - | - | - | 1件: 97 97 |
239 | HMPL-004 high dose | - | - | - | - | 1件: 97 97 |
240 | HMPL-004 low dose | - | - | - | - | 1件: 97 97 |
241 | HMPL-523 | - | - | - | - | 2件: 46 46, 63 |
242 | HMPL004-6599 | - | - | - | - | 2件: 96 96, 97 |
243 | HMR 1726D | - | - | - | - | 1件: 13 13 |
244 | HMR1726 | - | - | - | - | 1件: 13 13 |
245 | HMR1726D | - | - | - | - | 1件: 13 13 |
246 | HMSCs | - | - | - | - | 1件: 299 299 |
247 | Hologene 5 | - | - | - | - | 1件: 36 36 |
248 | Hologene 5 DS | - | - | - | - | 1件: 36 36 |
249 | HOLOGENE17 | - | - | - | - | 1件: 36 36 |
250 | HOLOGENE7 | - | - | - | - | 1件: 36 36 |
251 | HOMAR-IR diagnosis test | - | - | - | - | 1件: 299 299 |
252 | Home based balance training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 2件: 6 6, 13 |
253 | Home Oral Glucose Tolerance Test kit | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
254 | Homeostasis Model Assessment of insulin resistance (HOMA) | - | - | - | - | 1件: 17 17 |
255 | Homocysteine | 1件: Homocysteine Homocysteine | - | - | - | 1件: 229 229 |
256 | Homologous booster | - | - | - | - | 1件: 13 13 |
257 | Honey | 1件: Honey Honey | 1件: D06776
D06776
| - | - | 3件: 57 57, 98, 299 |
258 | Hookworm larvae | - | - | - | - | 1件: 13 13 |
259 | HORA-PDE6B (AAV2/5.hPDE6B) | - | - | - | - | 1件: 90 90 |
260 | Hormonal balance measurements | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 81 81 |
261 | Hormonal profile | - | - | - | - | 1件: 113 113 |
262 | Hormone (prednisone) | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 |
263 | Horse -Anti-thymocyte | - | - | - | - | 1件: 65 65 |
264 | Horse anti-thymocyte globulin | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
265 | Horse anti-thymocyte globulin (ATG) | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
266 | Horse anti-thymocyte globulin (hATG) | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | 1件: 60 60 |
267 | Horse chestnut | 1件: Horse chestnut Horse chestnut | 1件: D12028
D12028
| - | - | 1件: 210 210 |
268 | Horse-Anti-thymocyte-Globulin | - | - | - | - | 1件: 60 60 |
269 | Hourly dosing of the nychtemeral secretion of melatonin | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 202 202 |
270 | HOV-12020 (Palm tocotrienols complex) | - | - | - | - | 1件: 124 124 |
271 | HP 129Xe | - | - | - | - | 1件: 299 299 |
272 | Hp 129Xenon | - | - | - | - | 1件: 228 228 |
273 | HP 3He | - | - | - | - | 1件: 299 299 |
274 | HP-3000 (ropinirole hydrochloride patch) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
275 | HP-3000 placebo | - | - | - | - | 1件: 6 6 |
276 | HP-3000(ropinirole hydrochloride patch) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
277 | HP184 | - | - | - | - | 1件: 13 13 |
278 | HP802-247 | - | - | - | - | 1件: 36 36 |
279 | HPC cell infusion | - | - | - | - | 1件: 45 45 |
280 | HPC, A Infusion | - | - | - | - | 1件: 60 60 |
281 | HPN-100 | - | - | - | - | 1件: 251 251 |
282 | HPV prophylactic vaccine Gardasil | 1件: Human papillomavirus type 6 L1 capsid protein antigen Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件: 49 49 |
283 | HR19042 capsule | - | - | - | - | 1件: 66 66 |
284 | HR19042 Capsules | - | - | - | - | 1件: 66 66 |
285 | HRA052015 | - | - | - | - | 1件: 75 75 |
286 | HRA052015 (mifepristone) | 1件: Mifepristone Mifepristone | 1件: D00585
D00585
| 2件: NR3C1 NR3C1, PGR 💬 | 6件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 75 75 |
287 | HrIL-2 active | - | - | - | - | 3件: 46 46, 49, 53 |
288 | HRPC | - | - | - | - | 1件: 90 90 |
289 | HRPC DP | - | - | - | - | 1件: 90 90 |
290 | HST5040 | - | - | - | - | 2件: 245 245, 246 |
291 | HT-100 | - | - | - | - | 1件: 113 113 |
292 | HTD1801 | - | - | - | - | 1件: 94 94 |
293 | HTD1801 (BUDCA) | - | - | - | - | 1件: 93 93 |
294 | HTEA | - | - | - | - | 1件: 57 57 |
295 | HTK cardioplegia | - | - | - | - | 1件: 215 215 |
296 | HTLP | - | - | - | - | 1件: 65 65 |
297 | Hu Leptin (A-100) | 1件: Leptin Leptin | - | - | - | 1件: 265 265 |
298 | Hu MiK-Beta-1 | - | - | - | - | 1件: 26 26 |
299 | Huaiqihuang Granule | - | - | - | - | 1件: 63 63 |
300 | Huaiqinhuang | - | - | - | - | 1件: 224 224 |
301 | Huang qi gui zhi wu wu granule | - | - | - | - | 1件: 46 46 |
302 | HUC-MSC + DMARDs | - | - | - | - | 1件: 46 46 |
303 | HUC-MSC infusion (BC-U001) | - | - | - | - | 1件: 46 46 |
304 | HUC-MSC suspension | - | - | - | - | 1件: 46 46 |
305 | HuCNS-SC | - | - | - | - | 1件: 19 19 |
306 | HuCNS-SC cells | - | - | - | - | 1件: 139 139 |
307 | HuCNS-SC transplant in the lead-in phase | - | - | - | - | 1件: 139 139 |
308 | HuL001 | - | - | - | - | 1件: 13 13 |
309 | Hulio | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
310 | HuM291 | - | - | - | - | 2件: 96 96, 97 |
311 | Humalog Mix50 100 U/ml sospensione iniettabile | - | - | - | - | 1件: 78 78 |
312 | Human acylated ghrelin | 1件: Lenomorelin Lenomorelin | - | - | - | 1件: 78 78 |
313 | Human albumin | 1件: Albumin human Albumin human | 2件: D02792
D02792
,
D05424
| - | - | 2件: 2 2, 96 |
314 | HUMAN ALBUMIN AS MACROAGGREGATES | 1件: Albumin human Albumin human | 2件: D02792
D02792
,
D05424
| - | - | 1件: 96 96 |
315 | HUMAN ALBUMIN SOLUTION | 1件: Albumin human Albumin human | 2件: D02792
D02792
,
D05424
| - | - | 1件: 2 2 |
316 | Human allogeneic adipose tissue-derived mesenchymal stem cells expanded | - | - | - | - | 1件: 36 36 |
317 | Human Allogeneic WJ-MSCs | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 |
318 | Human Amniotic Epithelial Stem Cells | - | - | - | - | 1件: 6 6 |
319 | Human anti TNF-alpha monoclonal | - | - | - | - | 1件: 46 46 |
320 | Human anti TNF-alpha monoclonal antibody | - | - | - | - | 2件: 46 46, 84 |
321 | Human anti-IL 12/23 monoclonal antibody | - | - | - | - | 1件: 84 84 |
322 | Human Anti-IL-12 Antibody | - | - | - | - | 1件: 96 96 |
323 | Human anti-IL-12 IgG1 Mab | - | - | - | - | 1件: 13 13 |
324 | Human anti-IL-12 Mab | - | - | - | - | 1件: 13 13 |
325 | Human anti-IL6 monoclonal antibody | - | - | - | - | 1件: 46 46 |
326 | Human anti-IP10 monoclonal antibody | - | - | - | - | 2件: 96 96, 97 |
327 | Human anti-LINGO-1 monoclonal antibody | - | - | - | - | 1件: 13 13 |
328 | HUMAN ANTI-PROMYOSTATIN MONOCLONAL ANTIBODY | - | - | - | - | 1件: 3 3 |
329 | Human Anti-TNF IgG1 Monoclonal Antibody | - | - | - | - | 3件: 46 46, 97, 271 |
330 | Human anti-TNF-alpha monoclonal antibody | - | - | - | - | 3件: 46 46, 97, 107 |
331 | Human anti-TNFa monoclonal antibody | - | - | - | - | 1件: 271 271 |
332 | Human Anti-TNFalfa | - | - | - | - | 3件: 46 46, 97, 271 |
333 | Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody | - | - | - | - | 1件: 51 51 |
334 | Human autologous mesenchymal stem cells | - | - | - | - | 2件: 2 2, 13 |
335 | HUMAN COAGULATION FACTOR VIII | 1件: Antihemophilic factor human Antihemophilic factor human | - | - | - | 1件: 288 288 |
336 | Human coagulation Factor VIII / von Willebrand Factor | 2件: Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | 1件: 288 288 |
337 | Human coagulation factor VIII associated with Von Willebrand factor (VWF) | 2件: Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | 1件: 288 288 |
338 | HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX | 3件: Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | 1件: 288 288 |
339 | Human Coagulation FACTOR X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 |
340 | Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh | - | - | - | - | 1件: 36 36 |
341 | Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE) | - | - | - | - | 1件: 90 90 |
342 | Human factor X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 |
343 | Human fetal-derived Neural Stem Cells (hNSCs) | - | - | - | - | 1件: 13 13 |
344 | HUMAN FIBRINOGEN | 1件: Fibrinogen human Fibrinogen human | - | - | - | 1件: 65 65 |
345 | Human Fibrinogen Concentrate | 1件: Fibrinogen human Fibrinogen human | - | - | - | 1件: 65 65 |
346 | Human fibroblast-derived dermal substitute, Dermagraft | - | - | - | - | 1件: 36 36 |
347 | Human Glucocerebrosidase (prGCD) | 1件: Taliglucerase alfa Taliglucerase alfa | 1件: D09675
D09675
| 1件: GBA GBA 💬 | 4件: Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 |
348 | Human Growth Hormone | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 4件: 78 78, 187, 193, 265 |
349 | Human Growth Hormone (1-134) | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 78 78 |
350 | Human Heterologous Liver Cells | - | - | - | - | 1件: 251 251 |
351 | Human heterologous liver cells (for infusion) | - | - | - | - | 1件: 251 251 |
352 | HUMAN IGG4 ISOTYPE MONOCLONAL (IL2-RG) ANTIBODY | - | - | - | - | 1件: 60 60 |
353 | Human Immunglobulin G (IgG) | - | - | - | - | 1件: 65 65 |
354 | Human Immunoglobulin | - | - | - | - | 2件: 63 63, 65 |
355 | HUMAN IMMUNOGLOBULIN G | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 4件: 14 14, 50, 63, 65 |
356 | Human insulin | 1件: Insulin human Insulin human | 2件: D00085
D00085
,
D03230
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 2件: 96 96, 156 |
357 | Human interferon beta | 1件: Human interferon beta Human interferon beta | - | - | - | 2件: 13 13, 26 |
358 | Human interferon beta 1a (Rebif) | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
359 | Human interferon beta-1a and glatiramer acetate | 4件: Acetate Acetate, Glatiramer, Human interferon beta, Interferon beta-1a | 2件: D04318
D04318
,
D04554
| 22件: HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, IFNAR1, IFNAR2 💬 | 44件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 |
360 | Human interleukin-2 | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 1件: 35 35 |
361 | HUMAN LEUCOCYTE INTERFERON-ALPHA | - | - | - | - | 1件: 13 13 |
362 | Human Monoclonal Antibody (CNTO 1275) to Interleukin 12p-40 | - | - | - | - | 1件: 96 96 |
363 | Human monoclonal antibody (CNTO 1275) to interleukin-12p40 | - | - | - | - | 1件: 13 13 |
364 | Human monoclonal antibody directed against CD20 on B-cells | - | - | - | - | 1件: 46 46 |
365 | Human monoclonal antibody directed against complement 5 protein | - | - | - | - | 1件: 62 62 |
366 | Human neural stem cell | - | - | - | - | 1件: 6 6 |
367 | Human Neural Stem Cells | - | - | - | - | 2件: 2 2, 13 |
368 | Human normal 10% immunoglobulin for intravenous administration | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 14 14 |
369 | Human normal 10% immunoglobulin for intravenous administrationn | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 14 14 |
370 | Human normal immunoglobulin | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 9件: 11 11, 13, 14, 43, 45, 50, 51, 63, 65 |
371 | HUMAN NORMAL IMMUNOGLOBULIN (IV) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 4件: 11 11, 14, 63, 65 |
372 | Human normal immunoglobulin (IVIg) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 3件: 14 14, 50, 65 |
373 | Human normal immunoglobulin (SCIg) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 14 14 |
374 | Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
375 | Human normal immunoglobulin (subcutaneous) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
376 | HUMAN NORMAL IMMUNOGLOBULIN FOR | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
377 | Human normal immunoglobulin for intravenous (IV) administration | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 51 51 |
378 | Human normal immunoglobulin for intravenous administration | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 3件: 14 14, 51, 65 |
379 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 2件: 63 63, 65 |
380 | Human normal immunoglobulin for intravenous use (IVIG) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
381 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 63 63 |
382 | Human normal immunoglobulin for subcutaneous administration | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 2件: 51 51, 65 |
383 | Human Normal Immunoglobulin for Subcutaneous Administration (IGSC) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
384 | Human normal immunoglobulin G (IgG > 98% purity) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 3件: 14 14, 63, 65 |
385 | Human normal immunoglobulin G (IgG) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 11 11 |
386 | Human normal immunoglogulin (IVIg) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 50 50 |
387 | Human papillomavirus vaccination (Gardasil) | 1件: Human papillomavirus type 6 L1 capsid protein antigen Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件: 49 49 |
388 | Human Placenta-Derived Cells PDA001 Intravenous Infusion | - | - | - | - | 1件: 96 96 |
389 | Human Placental Derived Stem Cell | - | - | - | - | 4件: 19 19, 20, 60, 284 |
390 | HUMAN PLASMA FOR FRACTIONATION | - | - | - | - | 1件: 96 96 |
391 | Human primary Retinal Pigment Epithelial (HuRPE) cells | - | - | - | - | 1件: 90 90 |
392 | Human recombinant growth hormone | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 2件: 13 13, 299 |
393 | Human Recombinant IgG1, lambda | - | - | - | - | 1件: 46 46 |
394 | Human recombinant leptin (metreleptin) | 2件: Leptin Leptin, Metreleptin | 1件: D05014
D05014
| 1件: LEPR LEPR 💬 | 6件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬 | 1件: 265 265 |
395 | Human recombinant parathyroid Hormone | 1件: Parathyroid hormone Parathyroid hormone | 1件: D05364
D05364
| 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 |
396 | Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 172 172 |
397 | Human retinal progenitor cells | - | - | - | - | 1件: 90 90 |
398 | Human Retinal Progenitor Cells Drug Product | - | - | - | - | 1件: 90 90 |
399 | Human Secretin | 1件: Secretin human Secretin human | - | - | - | 1件: 298 298 |
400 | Human serum albumin | 1件: Albumin human Albumin human | 2件: D02792
D02792
,
D05424
| - | - | 1件: 78 78 |
401 | HUMAN SERUM ALBUMIN (HSA) FUSED TO RECOMBINANT HUMAN GROWTH HORMONE (HGH) | 2件: Albumin human Albumin human, Somatotropin | 3件: D02691
D02691
,
D02792
,
D05424
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 78 78 |
402 | Human Serum Albumin (HSA) fused to somatropin | 2件: Albumin human Albumin human, Somatotropin | 3件: D02691
D02691
,
D02792
,
D05424
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 78 78 |
403 | Human soluble recombinant Fc-gamma receptor IIB | - | - | - | - | 1件: 66 66 |
404 | Human Stem Cells | - | - | - | - | 1件: 6 6 |
405 | Human T Lymphoid Progenitor (HTLP) injection | - | - | - | - | 1件: 65 65 |
406 | Human Transthyretin Antisense Oligonucleotide | - | - | - | - | 1件: 28 28 |
407 | Human Umbilical Cord Blood-derived Mesenchymal Stem Cells | - | - | - | - | 1件: 36 36 |
408 | Human umbilical cord derived MSC transplantation for SLE | - | - | - | - | 1件: 49 49 |
409 | Human Umbilical Cord Mesenchymal Stem Cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 3件: 13 13, 96, 113 |
410 | Human umbilical cord mesenchymal stem cells (UC-MSCs) | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 96 96 |
411 | Human umbilical cord-derived MSCs | - | - | - | - | 1件: 271 271 |
412 | HUMAN VON WILLEBRAND FACTOR | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
413 | Human von Willebrand factor (VWF) and coagulation factor VIII (FVIII) | 2件: Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | 1件: 288 288 |
414 | Human VWF/FVIII concentrate | - | - | - | - | 1件: 288 288 |
415 | Humanised anti-CD 20 antibody | - | - | - | - | 1件: 46 46 |
416 | Humanised anti-CD4 IgG1 monoclonal | - | - | - | - | 1件: 46 46 |
417 | Humanised IgG1 monoclonal antibody against blood dendritic cell antigen 2 | - | - | - | - | 1件: 49 49 |
418 | Humanised IgG1 monoclonal antibody against human eotaxin-2 | - | - | - | - | 1件: 94 94 |
419 | Humanised IgG1K monoclonal antibody against interferon beta | 1件: Human interferon beta Human interferon beta | - | - | - | 1件: 50 50 |
420 | Humanized anti-alpha v beta 6 mAb | - | - | - | - | 1件: 85 85 |
421 | Humanized IgG1 kappa antiamyloid | - | - | - | - | 1件: 28 28 |
422 | Humanized IgG1, kappa anti-serum amyloid A and anti-AL amyloid antibody | - | - | - | - | 1件: 28 28 |
423 | Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody | - | - | - | - | 1件: 46 46 |
424 | Humanized recombinant IgG4 monoclonal antibody against CD-127 | - | - | - | - | 1件: 97 97 |
425 | Humanized TNFa monoclonal antibody | - | - | - | - | 1件: 46 46 |
426 | Humate-P | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
427 | Humatrope | - | - | - | - | 2件: 78 78, 274 |
428 | Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 193 193 |
429 | Humatrope® 6 mg, powder and solvent for solution for injection | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 78 78 |
430 | HuMax-CD20 | 1件: Ofatumumab Ofatumumab | 1件: D09314
D09314
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 46 |
431 | HUMAX-CD38 | - | - | - | - | 2件: 28 28, 63 |
432 | HuMax-CD38, 3003-005 | - | - | - | - | 1件: 28 28 |
433 | HuMax-CD4 | - | - | - | - | 1件: 46 46 |
434 | HUMIRA | - | - | - | - | 9件: 46 46, 56, 84, 96, 97, 107, 160, 269, 271 |
435 | Humira (adalimumab original) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
436 | HUMIRA (ADALIMUMAB) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 |
437 | Humira (adalimumab) 40 mg in 0.4 ml s.c. injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
438 | Humira (adalimumab) 40 mg s.c. injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
439 | Humira (adalimumab) 40mg in 0.4 ml s.c. injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
440 | Humira (adalimumab) 40mg in 0.4ml s.c.injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
441 | HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 56 56, 97 |
442 | HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 2 SIRINGHE PRERIEMPITE 0.8 ML + 2 TAMPONI IMBEVUTI DI ALCOL IN 1 BLISTER | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
443 | HUMIRA - 40MG/0.8ML SOLUZ. INIETTABILE- USO SOTTOCUTANEO-FLACONCINO(VETRO) 0.8ML 2 ASTUCCI:1 FLACONCINO+1SIRINGA+1AGO+1ADATT.STERILE-2TAMPONI IMBEVUTI ALCOOL | - | - | - | - | 2件: 46 46, 96 |
444 | Humira 20 mg solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
445 | Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
446 | Humira 40 mg injekcní roztok v predplnené injekcní stríkacce | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
447 | Humira 40 mg injeksjonsvæske, oppløsning, i ferdigfylt sprøyte | - | - | - | - | 1件: 46 46 |
448 | HUMIRA 40 mg solución inyectable en jeringa precargada | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 |
449 | Humira 40 mg solution for injection in pre-filled pen | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
450 | Humira 40 mg solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 |
451 | Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
452 | Humira 40 mg solution for injection in pre-filled syringes | - | - | - | - | 1件: 97 97 |
453 | Humira 40 mg/0.8 ml solution for injection | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 96, 97, 271 |
454 | Humira 40 mg/0.8 ml solution for injection for paediatric use | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
455 | Humira 40mg Injektionslösung | - | - | - | - | 1件: 46 46 |
456 | HUMIRA 40Mg Solution for Injection | - | - | - | - | 2件: 96 96, 97 |
457 | Humira 40mg solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
458 | Humira 40mg solution for injection in pre-filled syringe (adalimumab) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
459 | Humira 40mg/0.4ml pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
460 | Humira 40mg/0.8 ml solution for injection for paediatric use | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
461 | Humira 40mg/0.8ml solution for injection for paediatric use | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
462 | Humira 40mg/0.8ml solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
463 | Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
464 | Humira pre-filled PEN | - | - | - | - | 1件: 96 96 |
465 | Humira SC | - | - | - | - | 1件: 46 46 |
466 | HUMIRA ® | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
467 | Humira ® (Adalimumab) 40mg/0.8mL Pre-filled Syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
468 | HUMIRA*SC 2SIR+F 40MG 0,8ML+2T | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 |
469 | Humira, 40 mg solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
470 | Humira, Hulio, Amgevita, Hyrimoz, Idacio, Imraldi | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
471 | Humira® | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 |
472 | Humira® (adalimumab) | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
473 | Humira® 40 mg Injektionslösung in Fertigspritze | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
474 | Humira® 40 mg solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
475 | Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
476 | Hunterase | 1件: Idursulfase beta Idursulfase beta | 1件: D11025
D11025
| 1件: IDS IDS 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 |
477 | Huolingshengji Granules | - | - | - | - | 1件: 2 2 |
478 | Hyaluronan | 1件: Hyaluronic acid Hyaluronic acid | 1件: D08043
D08043
| - | - | 1件: 299 299 |
479 | Hyaluronate | 1件: Hyaluronic acid Hyaluronic acid | 1件: D08043
D08043
| - | - | 2件: 53 53, 97 |
480 | Hyaluronic acid | 1件: Hyaluronic acid Hyaluronic acid | 1件: D08043
D08043
| - | - | 5件: 46 46, 53, 70, 226, 231 |
481 | Hyaluronic Acid and Chondroitin Sulfate | 3件: Chondroitin sulfate Chondroitin sulfate, Hyaluronic acid, Sulfate ion | 1件: D08043
D08043
| - | - | 1件: 226 226 |
482 | Hyaluronic Acid Inhalation Solution | 1件: Hyaluronic acid Hyaluronic acid | 1件: D08043
D08043
| - | - | 1件: 231 231 |
483 | Hyaluronic acid/chondroitin sulfate | 3件: Chondroitin sulfate Chondroitin sulfate, Hyaluronic acid, Sulfate ion | 1件: D08043
D08043
| - | - | 1件: 226 226 |
484 | Hyaluronidase | 1件: Hyaluronidase Hyaluronidase | 3件: D04455
D04455
,
D04456
,
D06604
| - | - | 5件: 14 14, 28, 51, 65, 331 |
485 | Hyaluronidase injected intradermally | 1件: Hyaluronidase Hyaluronidase | 3件: D04455
D04455
,
D04456
,
D06604
| - | - | 1件: 51 51 |
486 | Hyaluronoglucosaminidase | 1件: Hyaluronidase Hyaluronidase | 3件: D04455
D04455
,
D04456
,
D06604
| - | - | 1件: 65 65 |
487 | Hydralazine | 1件: Hydralazine Hydralazine | 2件: D01302
D01302
,
D08044
| 1件: AOC3 AOC3 💬 | 5件: Glycine, serine and threonine metabolism Glycine, serine and threonine metabolism, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, beta-Alanine metabolism 💬 | 1件: 67 67 |
488 | Hydrochloorthiazide | - | - | - | - | 1件: 225 225 |
489 | HYDROCHLOROTHIAZIDE | 1件: Hydrochlorothiazide Hydrochlorothiazide | 1件: D00340
D00340
| 1件: SLC12A3 SLC12A3 💬 | - | 4件: 13 13, 67, 225, 235 |
490 | Hydrochlorothiazide/amiloride | 2件: Amiloride Amiloride, Hydrochlorothiazide | 3件: D00340
D00340
,
D00649
,
D07447
| 4件: SCNN1A SCNN1A, SCNN1B, SCNN1G, SLC12A3 💬 | - | 1件: 225 225 |
491 | Hydrocortison 100 mg (Pfizer®) in 2 ml solvent | - | - | - | - | 1件: 83 83 |
492 | Hydrocortisone | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 |
493 | Hydrocortisone (Solucortef) | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
494 | Hydrocortisone 100mg/ml | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 |
495 | Hydrocortisone 10mg | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
496 | Hydrocortisone 10mg Tablet | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
497 | Hydrocortisone 10mg Tablets | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
498 | Hydrocortisone 20mg Tablets | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
499 | HYDROCORTISONE ACETATE | 2件: Acetate Acetate, Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
500 | Hydrocortisone cream | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
501 | Hydrocortisone cream 1% | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
502 | Hydrocortisone cream 10mg/g FNA Fagron | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
503 | HYDROCORTISONE HYDROGEN SUCCINATE | 3件: Hydrocortisone Hydrocortisone, Hydrocortisone succinate, Hydrogen | 2件: D00088
D00088
,
D01442
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 |
504 | HYDROCORTISONE MICRONIZED | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
505 | Hydrocortisone Modified Release Capsules | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
506 | HYDROCORTISONE ROUSSEL | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 |
507 | Hydrocortisone sodium acetate | 3件: Acetate Acetate, Hydrocortisone, Sodium acetate | 2件: D00088
D00088
,
D01779
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
508 | HYDROCORTISONE SODIUM PHOSPHATE | 2件: Hydrocortisone Hydrocortisone, Phosphate ion | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 53 53, 81, 83 |
509 | HYDROCORTISONE SODIUM SUCCINATE | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 81 81, 83, 97 |
510 | Hydrocortisone tablet 2.5 mg | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
511 | Hydrocortisone TAKEDA, tabletter | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 |
512 | Hydrocortisone withdrawal | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
513 | HYDROCORTISONE- hydrocortisone tablet | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
514 | Hydrocortisonum | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 |
515 | Hydrocortone | - | - | - | - | 1件: 78 78 |
516 | Hydrogen | 1件: Hydrogen Hydrogen | - | - | - | 7件: 5 5, 6, 13, 17, 83, 97, 226 |
517 | Hydrogen peroxide | 2件: Hydrogen Hydrogen, Hydrogen peroxide | 1件: D00008
D00008
| - | - | 1件: 13 13 |
518 | Hydrokortison | - | - | - | - | 1件: 41 41 |
519 | Hydrokortison APL kapsel 2,5 mg | - | - | - | - | 1件: 83 83 |
520 | Hydrokortison Glostrup 5 mg | - | - | - | - | 1件: 78 78 |
521 | Hydrokortison orion | - | - | - | - | 1件: 41 41 |
522 | Hydrolyzed guar gum | 1件: Guar gum Guar gum | 1件: D04403
D04403
| - | - | 1件: 6 6 |
523 | Hydromorphone | 1件: Hydromorphone Hydromorphone | 2件: D00839
D00839
,
D08047
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 |
524 | Hydroxide | 1件: Hydroxide ion Hydroxide ion | - | - | - | 5件: 11 11, 46, 96, 97, 284 |
525 | Hydroxocobalamin | 1件: Hydroxocobalamin Hydroxocobalamin | 3件: D01027
D01027
,
D02707
,
D04929
| - | - | 1件: 97 97 |
526 | Hydroxocobalamin with Butyrate | 2件: Butyric Acid Butyric Acid, Hydroxocobalamin | 4件: D01027
D01027
,
D02707
,
D04929
,
D05866
| - | - | 1件: 97 97 |
527 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 27件: 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
528 | Hydroxychloroquine (Z0188) | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 49 49 |
529 | Hydroxychloroquine + low-dose prednisone | 2件: Hydroxychloroquine Hydroxychloroquine, Prednisone | 2件: D00473
D00473
,
D08050
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
530 | Hydroxychloroquine + Prednisone | 2件: Hydroxychloroquine Hydroxychloroquine, Prednisone | 2件: D00473
D00473
,
D08050
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
531 | Hydroxychloroquine 400mg/d | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 53 53 |
532 | Hydroxychloroquine and Indapamide | 2件: Hydroxychloroquine Hydroxychloroquine, Indapamide | 3件: D00345
D00345
,
D06401
,
D08050
| 1件: SLC12A3 SLC12A3 💬 | - | 1件: 13 13 |
533 | Hydroxychloroquine higher dose | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 90 90 |
534 | Hydroxychloroquine lower dose | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 90 90 |
535 | Hydroxychloroquine or Chloroquine | 2件: Chloroquine Chloroquine, Hydroxychloroquine | 4件: D02125
D02125
,
D02366
,
D03469
,
D08050
| - | - | 1件: 49 49 |
536 | Hydroxychloroquine reduced | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 49 49 |
537 | HYDROXYCHLOROQUINE SULFATE | 2件: Hydroxychloroquine Hydroxychloroquine, Sulfate ion | 1件: D08050
D08050
| - | - | 3件: 46 46, 53, 66 |
538 | Hydroxychloroquine Sulfate 100 milligram (mg) Tab | 2件: Hydroxychloroquine Hydroxychloroquine, Sulfate ion | 1件: D08050
D08050
| - | - | 1件: 218 218 |
539 | HYDROXYCHLOROQUINE SULPHATE | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 1件: 96 96 |
540 | Hydroxycholoquine | - | - | - | - | 1件: 46 46 |
541 | Hydroxycloroquina | - | - | - | - | 1件: 46 46 |
542 | Hydroxypropyl-beta-cyclodextrin | 1件: Betadex Betadex | 1件: D02401
D02401
| - | - | 1件: 19 19 |
543 | Hydroxypropyl-ß-cyclodextrin | - | - | - | - | 1件: 19 19 |
544 | HYDROXYPROPYLBETADEX | - | - | - | - | 1件: 19 19 |
545 | Hydroxytyrosol | 1件: Hydroxytyrosol Hydroxytyrosol | - | - | - | 1件: 13 13 |
546 | Hydroxyurea | 1件: Hydroxyurea Hydroxyurea | 1件: D00341
D00341
| 1件: RRM2 RRM2 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | 8件: 3 3, 13, 19, 20, 65, 85, 86, 284 |
547 | Hylase | - | - | - | - | 1件: 46 46 |
548 | HYNR-CS inj | - | - | - | - | 1件: 2 2 |
549 | HYNRCS-Allo inj | - | - | - | - | 1件: 2 2 |
550 | Hyperbaric Oxygen | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 2件: 46 46, 97 |
551 | Hyperbaric oxygen therapy | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 90 90 |
552 | Hypercortisolism | - | - | - | - | 1件: 75 75 |
553 | Hyperglycemic clamp | - | - | - | - | 1件: 299 299 |
554 | Hyperglycemic Clamp with concurrent GIP infusion | - | - | - | - | 1件: 299 299 |
555 | Hyperglycemic clamp with concurrent GLP-1 infusion | - | - | - | - | 1件: 299 299 |
556 | Hyperimmune caprine serum | - | - | - | - | 1件: 51 51 |
557 | Hyperimmune caprine serum against HIV lysate | - | - | - | - | 1件: 13 13 |
558 | Hyperinsulinemic euglycemic clamp | - | - | - | - | 2件: 316 316, 317 |
559 | HYPERIUM | 1件: Rilmenidine Rilmenidine | 1件: D08482
D08482
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 8 8 |
560 | Hyperoxia | - | - | - | - | 2件: 51 51, 85 |
561 | Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 85 85 |
562 | Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 85 85 |
563 | Hyperpolarized 129-Xenon gas | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 85 85 |
564 | Hyperpolarized 129Xe | - | - | - | - | 1件: 86 86 |
565 | Hyperpolarized 13C-Pyruvate | - | - | - | - | 1件: 58 58 |
566 | Hyperpolarized [1-13C]pyruvate | - | - | - | - | 2件: 2 2, 67 |
567 | Hyperpolarized Helium-3 | 2件: Helium Helium, Helium He-3 | 1件: D04420
D04420
| - | - | 1件: 299 299 |
568 | Hyperpolarized Helium-3 MRI | 2件: Helium Helium, Helium He-3 | 1件: D04420
D04420
| - | - | 1件: 228 228 |
569 | Hyperpolarized Helium-3 MRI of the chest | 2件: Helium Helium, Helium He-3 | 1件: D04420
D04420
| - | - | 1件: 299 299 |
570 | Hyperpolarized Xe129 | - | - | - | - | 2件: 85 85, 299 |
571 | Hyperpolarized Xenon | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
572 | Hyperpolarized Xenon 129 | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
573 | Hyperpolarized Xenon gas | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
574 | Hyperpolarized xenon-129 | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
575 | Hypersaline | - | - | - | - | 1件: 294 294 |
576 | Hypertonic bicarbonate | - | - | - | - | 1件: 299 299 |
577 | HYPERTONIC SALINE | - | - | - | - | 1件: 299 299 |
578 | Hypertonic saline (7 %) and isotonic saline (0.9%) | - | - | - | - | 1件: 299 299 |
579 | Hypertonic saline (7%) | - | - | - | - | 1件: 299 299 |
580 | Hypertonic saline 6% - | - | - | - | - | 1件: 299 299 |
581 | Hypertonic Saline 7% | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
582 | Hypertonic saline solution | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
583 | Hypoestoxide | - | - | - | - | 1件: 6 6 |
584 | HypotonicTreprostinil Solution | - | - | - | - | 1件: 86 86 |
585 | Hypoxic Gas Mixture | - | - | - | - | 1件: 6 6 |
586 | Hypro | - | - | - | - | 1件: 75 75 |
587 | HyQvia | 1件: Hyaluronidase (human recombinant) Hyaluronidase (human recombinant) | - | - | - | 2件: 14 14, 65 |
588 | HyQvia 100 mg/ml solution for infusion for subcutaneous use | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 1件: 65 65 |
589 | Hyrimoz | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 |
590 | HZN-825 | - | - | - | - | 2件: 51 51, 85 |
591 | HZN-825 BID | - | - | - | - | 1件: 51 51 |
592 | HZN-825 QD | - | - | - | - | 1件: 51 51 |
593 | HZT-501 | 1件: HZT-501 HZT-501 | - | - | - | 1件: 46 46 |